Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

Xiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, R. Donald Harvey, Ki Young Chung, Farhad Sedarati, Cassie Dong, Douglas V. Faller, Karthik Venkatakrishnan, Neeraj Gupta

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry

Physics

Engineering

Earth and Planetary Sciences